Kyung Bo Kim
- Molecular Biology top 5%
- Oncology top 5%
- Organic Chemistry top 10%
- Cell Biology top 5%
- Immunology top 10%
- Co-authors
- Craig M. CrewsJayhyuk MyungWooin LeeZachary MillerNorman KairiesM. GrollRobert HuberNy Sin
- Topics
- Ubiquitin and proteasome pathways (30 papers)Peptidase Inhibition and Analysis (22 papers)Protein Degradation and Inhibitors (14 papers)
- Cited by
- OncologyMolecular BiologyHematology
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Kyung Bo Kim
60 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.8k
- Oncology 769
- Organic Chemistry 293
- Cell Biology 272
- Immunology 268
Countries citing papers authored by Kyung Bo Kim
This map shows the geographic impact of Kyung Bo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung Bo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung Bo Kim more than expected).
Fields of papers citing papers by Kyung Bo Kim
This network shows the impact of papers produced by Kyung Bo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung Bo Kim. The network helps show where Kyung Bo Kim may publish in the future.
Co-authorship network of co-authors of Kyung Bo Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Kyung Bo Kim. A scholar is included among the top collaborators of Kyung Bo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung Bo Kim. Kyung Bo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 6 | |
| 6 | 12 | |
| 7 | 12 | |
| 8 | 22 | |
| 9 | 110 | |
| 10 | 33 | |
| 11 | 21 | |
| 12 | 26 | |
| 13 | Implications and Development of AHR-based Therapeutic Agents | 2 |
| 14 | 39 | |
| 15 | 19 | |
| 16 | 52 | |
| 17 | 11 | |
| 18 | 5 | |
| 19 | 103 | |
| 20 | 88 |
About Kyung Bo Kim
Kyung Bo Kim is a scholar working on Hematology, Oncology and Molecular Biology, having authored 61 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (30 papers), Peptidase Inhibition and Analysis (22 papers) and Protein Degradation and Inhibitors (14 papers). The work is most often cited by research in Oncology (769 citations), Molecular Biology (1.8k citations) and Hematology (265 citations). Kyung Bo Kim has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Craig M. Crews, Jayhyuk Myung, Wooin Lee, Zachary Miller, Norman Kairies, M. Groll, Robert Huber, Ny Sin, Ji Eun Park and Chang‐Guo Zhan. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.